183 related articles for article (PubMed ID: 23097213)
1. Novel screening assay for the selective detection of G-protein-coupled receptor heteromer signaling.
van Rijn RM; Harvey JH; Brissett DI; DeFriel JN; Whistler JL
J Pharmacol Exp Ther; 2013 Jan; 344(1):179-88. PubMed ID: 23097213
[TBL] [Abstract][Full Text] [Related]
2. A 1536-well cAMP assay for Gs- and Gi-coupled receptors using enzyme fragmentation complementation.
Weber M; Ferrer M; Zheng W; Inglese J; Strulovici B; Kunapuli P
Assay Drug Dev Technol; 2004 Feb; 2(1):39-49. PubMed ID: 15090209
[TBL] [Abstract][Full Text] [Related]
3. Cross-communication between G
Navarro G; Cordomí A; Brugarolas M; Moreno E; Aguinaga D; Pérez-Benito L; Ferre S; Cortés A; Casadó V; Mallol J; Canela EI; Lluís C; Pardo L; McCormick PJ; Franco R
BMC Biol; 2018 Feb; 16(1):24. PubMed ID: 29486745
[TBL] [Abstract][Full Text] [Related]
4. Expression of the third intracellular loop of the delta-opioid receptor inhibits signaling by opioid receptors and other G protein-coupled receptors.
Morou E; Georgoussi Z
J Pharmacol Exp Ther; 2005 Dec; 315(3):1368-79. PubMed ID: 16160084
[TBL] [Abstract][Full Text] [Related]
5. The human delta opioid receptor activates G(i1)alpha more efficiently than G(o1)alpha.
Moon HE; Cavalli A; Bahia DS; Hoffmann M; Massotte D; Milligan G
J Neurochem; 2001 Mar; 76(6):1805-13. PubMed ID: 11259498
[TBL] [Abstract][Full Text] [Related]
6. The δ opioid receptor agonist SNC80 selectively activates heteromeric μ-δ opioid receptors.
Metcalf MD; Yekkirala AS; Powers MD; Kitto KF; Fairbanks CA; Wilcox GL; Portoghese PS
ACS Chem Neurosci; 2012 Jul; 3(7):505-9. PubMed ID: 22860219
[TBL] [Abstract][Full Text] [Related]
7. Biased signaling through G-protein-coupled PROKR2 receptors harboring missense mutations.
Sbai O; Monnier C; Dodé C; Pin JP; Hardelin JP; Rondard P
FASEB J; 2014 Aug; 28(8):3734-44. PubMed ID: 24830383
[TBL] [Abstract][Full Text] [Related]
8. Co-expression of mu and delta opioid receptors as receptor-G protein fusions enhances both mu and delta signalling via distinct mechanisms.
Snook LA; Milligan G; Kieffer BL; Massotte D
J Neurochem; 2008 May; 105(3):865-73. PubMed ID: 18182056
[TBL] [Abstract][Full Text] [Related]
9. Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity.
Peters MF; Scott CW
J Biomol Screen; 2009 Mar; 14(3):246-55. PubMed ID: 19211780
[TBL] [Abstract][Full Text] [Related]
10. Agonists at the δ-opioid receptor modify the binding of µ-receptor agonists to the µ-δ receptor hetero-oligomer.
Kabli N; Martin N; Fan T; Nguyen T; Hasbi A; Balboni G; O'Dowd BF; George SR
Br J Pharmacol; 2010 Nov; 161(5):1122-36. PubMed ID: 20977461
[TBL] [Abstract][Full Text] [Related]
11. Studies on mu and delta opioid receptor selectivity utilizing chimeric and site-mutagenized receptors.
Wang WW; Shahrestanifar M; Jin J; Howells RD
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12436-40. PubMed ID: 8618916
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of opioid agonists on G protein expression in CHO cells expressing cloned human opioid receptors.
Xu H; Wang X; Partilla JS; Bishop-Mathis K; Benaderet TS; Dersch CM; Simpson DS; Prisinzano TE; Rothman RB
Brain Res Bull; 2008 Sep; 77(1):49-54. PubMed ID: 18639745
[TBL] [Abstract][Full Text] [Related]
13. Opioid and cannabinoid receptors share a common pool of GTP-binding proteins in cotransfected cells, but not in cells which endogenously coexpress the receptors.
Shapira M; Vogel Z; Sarne Y
Cell Mol Neurobiol; 2000 Jun; 20(3):291-304. PubMed ID: 10789829
[TBL] [Abstract][Full Text] [Related]
14. A role for the distal carboxyl tails in generating the novel pharmacology and G protein activation profile of mu and delta opioid receptor hetero-oligomers.
Fan T; Varghese G; Nguyen T; Tse R; O'Dowd BF; George SR
J Biol Chem; 2005 Nov; 280(46):38478-88. PubMed ID: 16159882
[TBL] [Abstract][Full Text] [Related]
15. Constitutive signaling of the human cytomegalovirus-encoded receptor UL33 differs from that of its rat cytomegalovirus homolog R33 by promiscuous activation of G proteins of the Gq, Gi, and Gs classes.
Casarosa P; Gruijthuijsen YK; Michel D; Beisser PS; Holl J; Fitzsimons CP; Verzijl D; Bruggeman CA; Mertens T; Leurs R; Vink C; Smit MJ
J Biol Chem; 2003 Dec; 278(50):50010-23. PubMed ID: 14522997
[TBL] [Abstract][Full Text] [Related]
16. δ-opioid receptor activation leads to neurite outgrowth and neuronal differentiation via a STAT5B-Gαi/o pathway.
Georganta EM; Tsoutsi L; Gaitanou M; Georgoussi Z
J Neurochem; 2013 Nov; 127(3):329-41. PubMed ID: 23906478
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors.
Knapp RJ; Santoro G; De Leon IA; Lee KB; Edsall SA; Waite S; Malatynska E; Varga E; Calderon SN; Rice KC; Rothman RB; Porreca F; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1996 Jun; 277(3):1284-91. PubMed ID: 8667189
[TBL] [Abstract][Full Text] [Related]
18. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
Childers SR; Fleming LM; Selley DE; McNutt RW; Chang KJ
Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233
[TBL] [Abstract][Full Text] [Related]
19. Multi-component signaling complexes of the delta-opioid receptor with STAT5B and G proteins.
Georganta EM; Agalou A; Georgoussi Z
Neuropharmacology; 2010 Sep; 59(3):139-48. PubMed ID: 20433855
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of Galpha(z)-specific sequence at the carboxyl terminus increases the promiscuity of galpha(16) toward G(i)-coupled receptors.
Mody SM; Ho MK; Joshi SA; Wong YH
Mol Pharmacol; 2000 Jan; 57(1):13-23. PubMed ID: 10617674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
